Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Michelle O'Donoghue Added: 7 months ago
AHA Scientific Sessions 2025 - Dr Michelle O'Donoghue (Brigham and Women's Hospital, US) joins us to discuss the evolving understanding of the causal relationship between elevated lipoprotein(a) and atherosclerotic cardiovascular disease, and what this means for risk stratification and management strategies in clinical practice.Dr O'Donoghue begins by highlighting the importance for clinicians to… View more
Author(s): Martin Swaans , Vijay Kunadian , , et al Added: 2 years ago
In this on-demand version of the live broadcast, chaired by Dr Martin Swaans (St Antonius Hospital, NL), faculty explore the evolving data for transcatheter aortic valve implantation (TAVI) and why we need to improve triaging practices towards the most appropriate interventions.Leading experts, Prof Sabine Bleiziffer (Heart and Diabetes Center NRW, DE), Prof Vijay Kunadian (Newcastle University,… View more
Author(s): Nils Krüger Added: 7 months ago
AHA Scientific Sessions 2025 - Dr Nils Krüger (Brigham and Women's Hospital, US) joins us to discuss findings from the TIRZSEMA-CVOT (NCT07096063) study, examining real-world cardiovascular outcomes with tirzepatide and semaglutide in patients with type 2 diabetes at cardiovascular risk.This retrospective cohort study utilized three national US claims databases to evaluate over 887,000 patients… View more
Author(s): Dipti Itchhaporia Added: 1 year ago
ACC 2025 - In this succinct video, Dr Dipti Itchhaporia (Hoag Heart and Vascular Institute & University of California, CA, US) outlines the key late-breaking trials from the conference that are expected to have an impact on clinical practice.Trials covered in detail include:FRESH-UPAPI-CATALIGN-ARPROTECT-TAVIRecorded on-site at ACC in Chicago, 2025.Support: This is an independent interview… View more
Author(s): Ambarish Pandey Added: 1 year ago
ACC 2025 - In this highlights video, Dr Ambarish Pandey (University of Texas Southwestern Medical Center, Texas, US) outlines the key late-breaking trials from the conference that are expected to have an impact on clinical practice.Trials covered in detail include:STRIDESOULFRESH-UPFAIR-HF 2Recorded on-site at ACC in Chicago, 2025.Support: This is an independent interview produced by Radcliffe… View more